for those at the extremes of the normal rangeDr Kelnar comments: I am grateful to Professor Boyd for his comments on my annotation. I hope that I emphasised sufficiently that explanation and reassurance may be all that is required. A decision has to be made on clinical grounds as to whether that is the case -a situation frequently faced by paediatric endocrinologists and many general paediatricians.
I also discussed the poor quality of some previous studies and the need for more scientific information before definitive recommendations can be given. In that regard, studies are in progress in a number of centres and a further contribution from this department is soon to be published in this journal. ' Selective and appropriate hormone treatment is not designed to 'narrow the range of normality' (nor will it do so) but to relieve distress.2 The extent to which it achieves that must also be assessed scientifically and such studies are also in progress in this department and elsewhere. Not all boys presenting with short stature and pubertal delay are 'future Professor Boyds' and some are likely to be significantly socially and psychologically disadvantaged at a time which is critically important for determining future After two years of treatment he was found to have central nervous system leukaemia and therefore was started on a relapse protocol (subsequently formulated as MRC UKALL RI). He tolerated this intensive regimen poorly and developed multidermatome shingles, so that after 16 weeks he was put on a maintenance regimen (vincristine, prednisolone, mercaptopurine, and methotrexate). He received a further 24 Gy of craniospinal irradiation.
After the later two year course of treatment the hair that regrew was only thin and wispy. It remained in this state for a period of 14 months. Minoxidil solution 2% was applied daily to the scalp. Over a period of nine months an almost normal head of hair was regained.
Abnormal hair growth was first noted as a side effect of the antihypertensive agent minoxidil. Topical minoxidil also stimulates hair growth and is used to treat male pattern baldness.' It has been tried, unsuccessfully, to modify acute hair loss during chemotherapy2; Abdominal pain is a very common symptom in patients with cystic fibrosis, but because of the recent concern about fibrotic strictures, radiological investigations into the cause of such pain are now being performed early. Our practice is to perform a plain abdominal radiograph and ultrasound of the bowel. If both these investigations are normnal, then there is little to be gained by proceeding to contrast studies. Detailed discussion with the parents of children in our area shows that they are keen that their children should not be labelled, either by badges or 'minders' in school. We must remember that these children are normal, but with a risk of serious reactions to foods.
Support to schools must emphasise prevention (that is, exclusion of allergens from the environment) and management of the (unlikely) reaction. Labelling children may in fact reduce the focus of removing the allergen from the environment and thereby increase the risk to the child. Many food allergens are not obvious (for example, nut oils in foods) and we must not rely on badges to protect these children. The labelling approach is dangerous and may lead to the segregation of these children from their peers. It may also lead to bullying of these children, and encourage other children to offer them the 'forbidden'' food. I would urge all paediatricians involved in the care of these children to reject this approach and concentrate on working with schools and parents to support these children in a sensitive way. After all, we do not put a badge on the child with a learning problem saying 'I'm stupid, please give me extra teaching'. Surely we can apply the same principles and sensitivity to children with potential anaphylactic reactions. 
